INTRODUCING IPS: A PROGNOSTIC BIOMARKER FOR PATIENTS ON ICI THERAPY /// LEARN MORE INTRODUCING IPS: A PROGNOSTIC BIOMARKER FOR PATIENTS ON ICI THERAPY /// LEARN MORE
ORDER A TEST Log In Contact Us
Back TO events
September 7 — 8, 2023 BOSTON, MA

Booth #E20
Plenary Session

13th Annual World Clinical Biomarkers & CDx Summit

Tempus is advancing precision medicine through the practical application of artificial intelligence in healthcare. We are pleased to attend the World CB & CDx Summit and present on how Tempus can support early development through commercial launch.

Schedule a meeting with us
Conference Session
September 7, 2023
live session
Time
5:00pm – 5:30pm EDT

Location
Omni Boston Hotel at the Seaport
450 Summer Street, Boston, Massachusetts, 02210
Presenter
Scott Melzer, VP of Business Development - Sequencing / CDx (Tempus)

Building a New CDx Ecosystem to Support Early Clinical Development Through Commercial Launch

  • Tempus combines RWD offering with CDx development to optimize biomarker design
  • Support trial enrollment using design controlled IUO tests
  • Improve speed to market using Tempus FDA-approved xT CDx assay
  • Immediate commercial access to 1000s of oncologists in the US and growing internationally

Schedule a meeting with us

We'll be in touch shortly.